. To determine the regions mediating sensitivity to Vif, we compared human APOBEC3F, which is HIV-1 Vif sensitive, with rhesus APOBEC3F, which is HIV-1 Vif resistant. Rhesus-human APOBEC3F chimeras and amino acid substitution mutants were tested for sensitivity to HIV-1 Vif. This approach identified the ␣3 and ␣4 helices of human APOBEC3F as important determinants of the interaction with HIV-1 Vif.
F
our APOBEC3 DNA cytosine deaminases have been demonstrated to restrict Vif-deficient HIV-1 in CD4-positive T cells (by many laboratories [reviewed in references 1 and 2]): APOBEC3D (A3D), APOBEC3F (A3F), APOBEC3G (A3G), and APOBEC3H (A3H). APOBEC3 proteins deaminate DNA cytosines to uracils, which during synthesis of the cDNA strand, provides a template for adenines, resulting in the characteristic Gto-A hypermutation observed in HIV-1 proviral sequences (3) (4) (5) . These mutations can be detrimental to the virus (6, 7) . HIV-1 Vif counteracts these host APOBEC3s by targeting them for ubiquitin-mediated proteasomal degradation (reviewed in references 2 and 8).
There is considerable interest in determining APOBEC3 motifs that govern the interaction with Vif. A3F provides a unique opportunity to advance this goal because the crystal structure of its catalytic domain, which also binds Vif, has been solved (9, 10) . Previous studies have interrogated this interaction by manipulating human A3F (huA3F), which is normally sensitive to HIV-1 Vif-mediated degradation, to become resistant to Vif-mediated degradation (11) (12) (13) . Here, the reciprocal approach is employed to determine the regions of A3F that mediate its sensitivity to HIV-1 Vif. We compared the A3F proteins from two primates: huA3F and rhesus macaque A3F (rhA3F). These proteins are 88% identical at the amino acid level and the same length, yet huA3F is sensitive to HIV-1 Vif-mediated degradation, whereas rhA3F is resistant (11, 14, 15) .
We previously showed that replacing an amino acid in huA3F with the reciprocal residue found in rhA3F (E324K) is sufficient to render huA3F resistant to HIV-1 Vif-mediated degradation, but the reverse amino acid substitution in rhA3F does not endow sensitivity to HIV-1 Vif (Fig. 1A) (11) . To elucidate a broader region in A3F involved in conferring sensitivity to HIV-1 Vif, a series of rhA3F (accession no. NM_001042373)-huA3F (accession no. NM_145298) chimeras was constructed with a C-terminal V5 tag (Fig. 1B) (11) . The restriction potential and Vif sensitivity of these A3F constructs were determined by cotransfection into 293T cells with HIV-1 clone pIIIB proviral DNA (GenBank accession no. EU541617), either expressing wild-type Vif (Vif proficient) or tandem-stop Vif (Vif deficient), followed by immunoblot analyses and infectivity assays (16, 17) .
huA3F restricted the infectivity of Vif-deficient HIV-1 and to a lesser extent Vif-proficient virus ( Fig. 2A) . In contrast, rhA3F restricted both Vif-deficient and Vif-proficient HIV-1 with similar potencies. Related to these viral restriction phenotypes, huA3F was degraded in the presence of HIV-1 Vif, while rhA3F protein was largely unaffected. A series of four chimeras mapped the HIV-1 Vif susceptibility determinants to an huA3F region spanning residue 278 to the C terminus ( Fig. 2A) .
To further delineate the Vif interaction region, a series of additional chimeras and amino acid substitution mutants were constructed based on known secondary structural elements ( Fig. 1B  and 2B ). Although several constructs showed intermediate phenotypes, only the rhA3F-hu␣3,4-EK/QE chimera had a reproducible and full sensitivity to HIV-1 Vif. This was evident for both infectivity and immunoblot phenotypes ( Fig. 2B ) and was significant upon quantification of data from multiple independent experiments (Fig. 2C) .
To further assess the restriction capabilities of key constructs, a panel of A3F-expressing SupT11 clones was generated using previously described methods (18) . SupT11 cells do not express APOBEC3s and are therefore permissive for Vif-deficient HIV-1 replication [for examples, see Fig. 3 and references 17 and 18). Clones expressing low and high levels of each A3F construct were chosen for experiments (Fig. 3A) . At least one clone per construct expressed A3F at H9-like levels, which resemble the amounts in primary CD4-positive lymphocytes (18) . Vif-proficient or Vifdeficient HIV-1 was used to infect these clones, and virus replication was monitored over time by applying culture supernatants to CEM-GFP reporter cells, followed by green fluorescent proteinpositive flow cytometry for quantification (17) .
In agreement with prior observations with this experimental system (17, 19) , Vif-deficient HIV-1 was restricted by huA3F, while Vif-proficient HIV-1 was able to replicate in the presence of both low and high levels of huA3F (Fig. 3B, upper left panel) . Both Vif-deficient and Vif-proficient HIV-1 were able to replicate on cells expressing low levels of rhA3F, although the Vif-deficient virus exhibited a considerable growth delay (Fig. 3B , upper middle panel). Neither virus was able to replicate on cells expressing high levels of rhA3F. These results highlight the relative resistance of rhA3F to HIV-1 Vif. The viral replication kinetics on cells expressing rhA3F-EK323-324QE were similar to those observed on rhA3F-expressing cells, indicating that rhA3F-EK323-324QE is also not fully sensitive to HIV-1 Vif (Fig. 3B , bottom middle panel). Most importantly, viral replication kinetics on SupT11 cells expressing rhA3F-hu␣3,4-EK/QE were similar to those of viruses on cells expressing huA3F (Fig. 3B , compare bottom and top left panels). These data further demonstrate that the differences in HIV-1 Vif sensitivity between huA3F and rhA3F map to the ␣3 and ␣4 helices of A3F.
The ␣3 and ␣4 helices of A3F define a negatively charged surface (Fig. 4) . These surface electrostatics are consistent with the recently published structure of the five-membered Vif complex (Vif-CBF-␤-CUL5-ELOB-ELOC), which implicates a positively charged region on Vif for interaction with the various Vif-sensitive APOBEC3 proteins (20 . Purified viral particles were blotted for V5 to detect A3F and p24 (Gag). A schematic of each construct is shown, with huA3F-derived residues represented in white and rhA3F residues represented in gray. (C) The ratio of Vif-proficient HIV-1 infectivity to Vif-deficient infectivity is plotted using the data from panel B. One-way analysis of variance (ANOVA) was used to compare these values, and Dunnett's method was employed for post hoc testing. Data for constructs significantly different from rhA3F (P Ͻ 0.05) are represented by black bars, and P values are shown to highlight the most important comparisons (ns, not significant).
sent the first interspecies example of altering an A3F protein that is normally resistant to HIV-1 Vif-mediated degradation (rhA3F) such that it becomes sensitized. Our results extend prior studies of the A3F-Vif interaction (11-13) by highlighting the importance of an extensive surface on A3F defined by the ␣3 and ␣4 helices for HIV-1 Vif-mediated degradation of this restriction factor. With the recent publication of the crystal structure of HIV-1 Vif (20), these findings are a timely addition to the APOBEC3-Vif interaction knowledge portfolio and provide information that may be used to interpret future crystal structures of the A3F-Vif complex and also potentially inform the development of novel therapeutics. The residues indicated define a negatively charged surface (red), as seen in an electrostatic potential surface map of A3F. (C) Alignment of the regions determined to be important for conveying sensitivity to degradation by HIV-1 Vif in huA3F and rhA3F. The residues in ␣ helices three and four that differ between huA3F and rhA3F are highlighted in yellow. Active-site residues that coordinate the zinc atom are indicated by black dots.
